From Zacks...
https://dailyquint.com/2017-02-19-concordia-international-corp-cxrx-lifted-to-hold-at-zacks-investment-research/
Canaccord Genuity ''BUY'' at $10 rating
Bloom Burton reissued a “HOLD” rating
RBC Capital Markets ''Outperform'' at $18.50 rating
Scotiabank reaffirmed a “sector perform” rating and set a $4.50 price objective
Concordia International Corp. has an average rating of “Hold” and an average price target of $28.16 A number of hedge funds have recently bought and sold shares of CXRX. Point72 Asset Management L.P. boosted its position in Concordia International Corp. by 1,738.9% in the second quarter. Point72 Asset Management L.P. now owns 1,197,100 shares of the company’s stock worth $25,786,000 after buying an additional 1,132,000 shares during the last quarter.
Taylor Asset Management Inc. boosted its position in Concordia International Corp. by 244.0% in the second quarter. Taylor Asset Management Inc. now owns 923,400 shares of the company’s stock worth $19,895,000 after buying an additional 655,000 shares during the last quarter.
Vanguard Group Inc. boosted its position in Concordia International Corp. by 9.1% in the second quarter. Vanguard Group Inc. now owns 715,117 shares of the company’s stock worth $15,404,000 after buying an additional 59,893 shares during the last quarter.
Nomura Holdings Inc. boosted its position in Concordia International Corp. by 1,183.4% in the second quarter. Nomura Holdings Inc. now owns 552,150 shares of the company’s stock worth $11,939,000 after buying an additional 509,127 shares during the last quarter. Finally, HealthInvest Partners AB purchased a new position in Concordia International Corp. during the second quarter worth about $11,696,000. 36.96% of the stock is owned by institutional investors and hedge funds.
So... I think were good...